Serum Institute of India

No immediate change in the dose range of the Covishield vaccine; Respect the NTAGI decision: Center

New Delhi: The government informed on Friday that there would be no change in the interval between doses of Covishield vaccine, immediately adding that scientific evidence had been gathered to review the decision at the next NEGVAC meeting. A recent Lancet study suggested that it would be better to narrow this gap between doses, in …

No immediate change in the dose range of the Covishield vaccine; Respect the NTAGI decision: Center Read More »

Biocon Biologics, Serum Institute Life Sciences announces strategic alliance

The Board of Directors of Biocon Biologics Limited (BBL), a subsidiary of Biocon Limited, on September 16 approved the merger of Covidshield Technologies Private Limited (CTLP) – a wholly owned subsidiary of Serum Institute Life Sciences Private Limited (SILS) – into BBL. Under this alliance, the BBL will be able to acquire 100 million doses …

Biocon Biologics, Serum Institute Life Sciences announces strategic alliance Read More »

Scroll to Top